Article
EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients.
Journal of neuro-oncology - 1 Feb 2007
Ribeiro Ricardo, Soares Angelo, Pinto Daniela, Catarino Raquel, Lopes Carlos, Medeiros Rui
Abstract excerpt
Neurofibromatosis type 1 (NF1) is characterized by a wide variation in clinical presentation and in some cases progression to malignant tumor. Epidermal growth factor (EGF) is an important mitogen for Schwann cells and is involved in the development of malignant tumors in NF1 patients. We hypothesized that EGF +61 G/A functional polymorphism, which represents constitutional all-life exposure to higher EGF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
